Shopping Cart 0
Cart Subtotal
AED 0

Respiratory Disease Testing Market (Imaging, Spirometry, Peak Flow, Blood Gas, Lung Volume, and other Tests) for Hospitals, Physician Offices and Clinical Laboratories: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 - 2021

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 15410

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 23117

Details

The report provides analysis and forecast for the respiratory disease testing market on a regional and global level. The study covers historic data of 2015 provided along with a forecast from 2016 to 2021 based on revenue (USD billion). The study provides restraints and drivers for the respiratory disease testing market coupled along with the impact they have on the demand over the forecast period. Moreover, the report also covers the analysis of opportunities present in the respiratory disease testing market on a global level. With the objective to give the users of this report a complete and clear view on the respiratory disease testing market and to better understand the competitive landscape in the market, an analysis of Porters Five Forces model for the respiratory disease testing market has also been covered. The study provides with a comprehensive market attractiveness analysis, wherein product segments and end-user segments are based on their growth rate, market size, and general attractiveness. The study provides a clear view on the respiratory disease testing market by segmenting the market based on end-user segment, product segment, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021. Based on product segment, the respiratory disease testing market has been segmented into imaging, spirometry, peak flow, blood gas, lung volume, and other tests. Based on the end-user segment, the respiratory disease testing market has been segmented into physician offices, hospitals, and clinical laboratories. The regional segmentation includes the current and forecast demand for Latin America, North America, Asia-Pacific, Europe, and the Middle East and Africa with its further bifurcation into major countries including Germany, France, UK, China, Japan, India, U.S. AND Brazil. The report also includes comprehensive profiles of end players such as ndd Medical Technologies, Inc., Carestream Health, Inc., SDI Diagnostics, Nihon Kohden Corporation, CareFusion Corporation, Smiths Medical, COSMED, Perkin Elmer, Inc., Philips Healthcare, MGC Diagnostic Corporation, Futuremed America, Inc. GE Healthcare and others. The thorough description of players includes parameters such as company overview, business, financial overview, and recent developments of the company. This report segments the global respiratory disease testing market as follows: Global Respiratory Disease Testing Market: Product Segment Analysis Lung Volume Imaging Spirometry Peak Flow Blood Gas Other Tests Global Respiratory Disease Testing Market: End-user Segment Analysis Hospitals Physician Offices Clinical Laboratories Global Respiratory Disease Testing Market: Regional Segment Analysis North America U.S. Europe UK France Germany Asia Pacific China Japan India Latin America Brazil Middle East and Africa

READ MORE

Table Of Content

Scope

Chapter 1. Introduction 1.1. Report description and scope 1.2. Research scope 1.3. Research methodology 1.3.1. Market research process 1.3.2. Market research methodology Chapter 2. Executive Summary 2.1. Global Respiratory Disease Testing market, 2015-2021 (USD Billion) 2.2. Global Respiratory Disease Testing market: Snapshot Chapter 3. Respiratory Disease Testing Market Dynamics 3.1. Introduction 3.2. Value chain analysis 3.3. Market drivers 3.3.1. Increase in Prevalence of Respiratory Diseases 3.3.2. Changing Lifestyle and Improvement in Medical Facilities 3.4. Market restraints 3.4.1. Low adoption rate of advanced spirometers and digital radiography systems 3.5. Opportunities 3.5.1. Huge Potential Presented by Emerging Markets in Asia-Pacific 3.6. Porters five forces analysis 3.6.1. Bargaining power of suppliers 3.6.2. Bargaining power of buyers 3.6.3. Threat from new entrants 3.6.4. Threat from new substitutes 3.6.5. Degree of competition 3.7. Market attractiveness analysis 3.7.1. Market attractiveness analysis, by product segment 3.7.2. Market attractiveness analysis, by end-user segment 3.7.3. Market attractiveness analysis, by regional segment Chapter 4. Global Respiratory Disease Testing Market Competitive Landscape 4.1. Company market share, 2015 (Subject to data availability) 4.2. Price trend analysis Chapter 5. Global Respiratory Disease Testing Market Product Segment Analysis 5.1. Global Respiratory Disease Testing market: Product segment overview 5.1.1. Global Respiratory Disease Testing market revenue share, by product segment, 2015 and 2021 5.2. Lung Volume 5.2.1. Global Lung Volume market , 2015 2021 (USD Billion) 5.3. Imaging 5.3.1. Global Imaging market, 2015 2021 (USD Billion) 5.4. Spirometry 5.4.1. Global Spirometry market, 2015 2021 (USD Billion) 5.5. Peak Flow 5.5.1. Global Peak Flow market, 2015 2021 (USD Billion) 5.6. Blood Gas 5.6.1. Global Blood Gas market, 2015 2021 (USD Billion) 5.7. Others 5.7.1. Global Other Tests market, 2015 2021 (USD Billion) Chapter 6. Global Respiratory Disease Testing Market End-user Segment Analysis 6.1. Global Respiratory Disease Testing market: End-user segment overview 6.1.1. Global Respiratory Disease Testing market revenue share, by End-user segment, 2015 and 2021 6.2. Hospitals 6.2.1. Global Hospitals market , 2015 2021 (USD Billion) 6.3. Physician Offices 6.3.1. Global Physician Offices market, 2015 2021 (USD Billion) 6.4. Clinical Laboratories 6.4.1. Global Clinical Laboratories market, 2015 2021 (USD Billion) Chapter 7. Global Respiratory Disease Testing Market Regional Segment Analysis 7.1. Global Respiratory Disease Testing Market: Regional Overview 7.1.1. Global Respiratory Disease Testing Market Volume Share By Region, 2015 And 2021 7.2. North America 7.2.1. North America Respiratory Disease Testing Market Revenue, By Product, 2015 2021, (USD Billion) 7.2.2. North America Respiratory Disease Testing Market Revenue, By End-User, 2015 2021, (USD Billion) 7.2.3. U.S. 7.2.3.1. U.S. Respiratory Disease Testing Market Revenue, By Product, 2015 2021, (USD Billion) 7.2.3.2. U.S. Respiratory Disease Testing Market Revenue, By End-User, 2015 2021 (USD Billion) 7.3. Europe 7.3.1. Europe Respiratory Disease Testing Market Revenue, By Product, 2015 2021, (USD Billion) 7.3.2. Europe Respiratory Disease Testing Market Revenue, By End-User, 2015 2021 (USD Billion) 7.3.3. UK 7.3.3.1. UK Respiratory Disease Testing Market Revenue, By Product, 2015 2021, (USD Billion) 7.3.3.2. UK Respiratory Disease Testing Market Revenue, By End-User, 2015 2021 (USD Billion) 7.3.4. France 7.3.4.1. France Respiratory Disease Testing Market Revenue, By Product, 2015 2021, (USD Billion) 7.3.4.2. France Respiratory Disease Testing Market Revenue, By End-User, 2015 2021, (USD Billion) 7.3.5. Germany 7.3.5.1. Germany Respiratory Disease Testing Market Revenue, By Product, 2015 2021, (USD Billion) 7.3.5.2. Germany Respiratory Disease Testing Market Revenue, By End-User, 2015 2021, (USD Billion) 7.4. Asia Pacific 7.4.1. Asia Pacific Respiratory Disease Testing Market Revenue, By Product, 2015 2021, (USD Billion) 7.4.2. Asia Pacific Respiratory Disease Testing Market Revenue, By End-User, 2015 2021 (USD Billion) 7.4.3. China 7.4.3.1. China Respiratory Disease Testing Market Revenue, By Product, 2015 2021, (USD Billion) 7.4.3.2. China Respiratory Disease Testing Market Revenue, By End-User, 2015 2021 (USD Billion) 7.4.4. Japan 7.4.4.1. Japan Respiratory Disease Testing Market Revenue, By Product, 2015 2021, (USD Billion) 7.4.4.2. Japan Respiratory Disease Testing Market Revenue, By End-User, 2015 2021 (USD Billion) 7.4.5. India 7.4.5.1. India Respiratory Disease Testing Market Revenue, By Product, 2015 2021, (USD Billion) 7.4.5.2. India Respiratory Disease Testing Market Revenue, By End-User, 2015 2021 (USD Billion) 7.5. Latin America 7.5.1. Latin America Respiratory Disease Testing Market Revenue, By Product, 2015 2021, (USD Billion) 7.5.2. Latin America Respiratory Disease Testing Market Revenue, By End-User, 2015 2021 (USD Billion) 7.5.3. Brazil 7.5.3.1. Brazil Respiratory Disease Testing Market Revenue, By Product, 2015 2021, (USD Billion) 7.5.3.2. Brazil Respiratory Disease Testing Market Revenue, By End-User, 2015 2021 (USD Billion) 7.6. Middle East And Africa 7.6.1. Middle East And Africa Respiratory Disease Testing Market Revenue, By Product, 2015 2021, (USD Billion) 7.6.2. Middle East And Africa Respiratory Disease Testing Market Revenue, By End-User, 2015 2021 (USD Billion) Chapter 8. Company Profile 8.1. ndd Medical Technologies, Inc. 8.1.1. Overview 8.1.2. Financials 8.1.3. Product Portfolio 8.1.4. Business Strategy 8.1.5. Recent Developments 8.2. Carestream Health, Inc. 8.2.1. Overview 8.2.2. Financials 8.2.3. Product Portfolio 8.2.4. Business Strategy 8.2.5. Recent Developments 8.3. SDI Diagnostics 8.3.1. Overview 8.3.2. Financials 8.3.3. Product Portfolio 8.3.4. Business Strategy 8.3.5. Recent Developments 8.4. Nihon Kohden Corporation 8.4.1. Overview 8.4.2. Financials 8.4.3. Product Portfolio 8.4.4. Business Strategy 8.4.5. Recent Developments 8.5. CareFusion Corporation 8.5.1. Overview 8.5.2. Financials 8.5.3. Product Portfolio 8.5.4. Business Strategy 8.5.5. Recent Developments 8.6. Smiths Medical 8.6.1. Overview 8.6.2. Financials 8.6.3. Product Portfolio 8.6.4. Business Strategy 8.6.5. Recent Developments 8.7. COSMED 8.7.1. Overview 8.7.2. Financials 8.7.3. Product Portfolio 8.7.4. Business Strategy 8.7.5. Recent Developments 8.8. Perkin Elmer, Inc. 8.8.1. Overview 8.8.2. Financials 8.8.3. Product Portfolio 8.8.4. Business Strategy 8.8.5. Recent Developments 8.9. Philips Healthcare 8.9.1. Overview 8.9.2. Financials 8.9.3. Product Portfolio 8.9.4. Business Strategy 8.9.5. Recent Developments 8.10. MGC Diagnostic Corporation 8.10.1. Overview 8.10.2. Financials 8.10.3. Product Portfolio 8.10.4. Business Strategy 8.10.5. Recent Developments 8.11. Futuremed America, Inc. 8.11.1. Overview 8.11.2. Financials 8.11.3. Product Portfolio 8.11.4. Business Strategy 8.11.5. Recent Developments 8.12. GE Healthcare 8.12.1. Overview 8.12.2. Financials 8.12.3. Product Portfolio 8.12.4. Business Strategy 8.12.5. Recent Developments

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

The report provides analysis and forecast for the respiratory disease testing market on a regional and global level. The study covers historic data of 2015 provided along with a forecast from 2016 to 2021 based on revenue (USD billion). The study provides restraints and drivers for the respiratory disease testing market coupled along with the impact they have on the demand over the forecast period. Moreover, the report also covers the analysis of opportunities present in the respiratory disease testing market on a global level. With the objective to give the users of this report a complete and clear view on the respiratory disease testing market and to better understand the competitive landscape in the market, an analysis of Porters Five Forces model for the respiratory disease testing market has also been covered. The study provides with a comprehensive market attractiveness analysis, wherein product segments and end-user segments are based on their growth rate, market size, and general attractiveness. The study provides a clear view on the respiratory disease testing market by segmenting the market based on end-user segment, product segment, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021. Based on product segment, the respiratory disease testing market has been segmented into imaging, spirometry, peak flow, blood gas, lung volume, and other tests. Based on the end-user segment, the respiratory disease testing market has been segmented into physician offices, hospitals, and clinical laboratories. The regional segmentation includes the current and forecast demand for Latin America, North America, Asia-Pacific, Europe, and the Middle East and Africa with its further bifurcation into major countries including Germany, France, UK, China, Japan, India, U.S. AND Brazil. The report also includes comprehensive profiles of end players such as ndd Medical Technologies, Inc., Carestream Health, Inc., SDI Diagnostics, Nihon Kohden Corporation, CareFusion Corporation, Smiths Medical, COSMED, Perkin Elmer, Inc., Philips Healthcare, MGC Diagnostic Corporation, Futuremed America, Inc. GE Healthcare and others. The thorough description of players includes parameters such as company overview, business, financial overview, and recent developments of the company. This report segments the global respiratory disease testing market as follows: Global Respiratory Disease Testing Market: Product Segment Analysis Lung Volume Imaging Spirometry Peak Flow Blood Gas Other Tests Global Respiratory Disease Testing Market: End-user Segment Analysis Hospitals Physician Offices Clinical Laboratories Global Respiratory Disease Testing Market: Regional Segment Analysis North America U.S. Europe UK France Germany Asia Pacific China Japan India Latin America Brazil Middle East and Africa

READ MORE

Scope

Chapter 1. Introduction 1.1. Report description and scope 1.2. Research scope 1.3. Research methodology 1.3.1. Market research process 1.3.2. Market research methodology Chapter 2. Executive Summary 2.1. Global Respiratory Disease Testing market, 2015-2021 (USD Billion) 2.2. Global Respiratory Disease Testing market: Snapshot Chapter 3. Respiratory Disease Testing Market Dynamics 3.1. Introduction 3.2. Value chain analysis 3.3. Market drivers 3.3.1. Increase in Prevalence of Respiratory Diseases 3.3.2. Changing Lifestyle and Improvement in Medical Facilities 3.4. Market restraints 3.4.1. Low adoption rate of advanced spirometers and digital radiography systems 3.5. Opportunities 3.5.1. Huge Potential Presented by Emerging Markets in Asia-Pacific 3.6. Porters five forces analysis 3.6.1. Bargaining power of suppliers 3.6.2. Bargaining power of buyers 3.6.3. Threat from new entrants 3.6.4. Threat from new substitutes 3.6.5. Degree of competition 3.7. Market attractiveness analysis 3.7.1. Market attractiveness analysis, by product segment 3.7.2. Market attractiveness analysis, by end-user segment 3.7.3. Market attractiveness analysis, by regional segment Chapter 4. Global Respiratory Disease Testing Market Competitive Landscape 4.1. Company market share, 2015 (Subject to data availability) 4.2. Price trend analysis Chapter 5. Global Respiratory Disease Testing Market Product Segment Analysis 5.1. Global Respiratory Disease Testing market: Product segment overview 5.1.1. Global Respiratory Disease Testing market revenue share, by product segment, 2015 and 2021 5.2. Lung Volume 5.2.1. Global Lung Volume market , 2015 2021 (USD Billion) 5.3. Imaging 5.3.1. Global Imaging market, 2015 2021 (USD Billion) 5.4. Spirometry 5.4.1. Global Spirometry market, 2015 2021 (USD Billion) 5.5. Peak Flow 5.5.1. Global Peak Flow market, 2015 2021 (USD Billion) 5.6. Blood Gas 5.6.1. Global Blood Gas market, 2015 2021 (USD Billion) 5.7. Others 5.7.1. Global Other Tests market, 2015 2021 (USD Billion) Chapter 6. Global Respiratory Disease Testing Market End-user Segment Analysis 6.1. Global Respiratory Disease Testing market: End-user segment overview 6.1.1. Global Respiratory Disease Testing market revenue share, by End-user segment, 2015 and 2021 6.2. Hospitals 6.2.1. Global Hospitals market , 2015 2021 (USD Billion) 6.3. Physician Offices 6.3.1. Global Physician Offices market, 2015 2021 (USD Billion) 6.4. Clinical Laboratories 6.4.1. Global Clinical Laboratories market, 2015 2021 (USD Billion) Chapter 7. Global Respiratory Disease Testing Market Regional Segment Analysis 7.1. Global Respiratory Disease Testing Market: Regional Overview 7.1.1. Global Respiratory Disease Testing Market Volume Share By Region, 2015 And 2021 7.2. North America 7.2.1. North America Respiratory Disease Testing Market Revenue, By Product, 2015 2021, (USD Billion) 7.2.2. North America Respiratory Disease Testing Market Revenue, By End-User, 2015 2021, (USD Billion) 7.2.3. U.S. 7.2.3.1. U.S. Respiratory Disease Testing Market Revenue, By Product, 2015 2021, (USD Billion) 7.2.3.2. U.S. Respiratory Disease Testing Market Revenue, By End-User, 2015 2021 (USD Billion) 7.3. Europe 7.3.1. Europe Respiratory Disease Testing Market Revenue, By Product, 2015 2021, (USD Billion) 7.3.2. Europe Respiratory Disease Testing Market Revenue, By End-User, 2015 2021 (USD Billion) 7.3.3. UK 7.3.3.1. UK Respiratory Disease Testing Market Revenue, By Product, 2015 2021, (USD Billion) 7.3.3.2. UK Respiratory Disease Testing Market Revenue, By End-User, 2015 2021 (USD Billion) 7.3.4. France 7.3.4.1. France Respiratory Disease Testing Market Revenue, By Product, 2015 2021, (USD Billion) 7.3.4.2. France Respiratory Disease Testing Market Revenue, By End-User, 2015 2021, (USD Billion) 7.3.5. Germany 7.3.5.1. Germany Respiratory Disease Testing Market Revenue, By Product, 2015 2021, (USD Billion) 7.3.5.2. Germany Respiratory Disease Testing Market Revenue, By End-User, 2015 2021, (USD Billion) 7.4. Asia Pacific 7.4.1. Asia Pacific Respiratory Disease Testing Market Revenue, By Product, 2015 2021, (USD Billion) 7.4.2. Asia Pacific Respiratory Disease Testing Market Revenue, By End-User, 2015 2021 (USD Billion) 7.4.3. China 7.4.3.1. China Respiratory Disease Testing Market Revenue, By Product, 2015 2021, (USD Billion) 7.4.3.2. China Respiratory Disease Testing Market Revenue, By End-User, 2015 2021 (USD Billion) 7.4.4. Japan 7.4.4.1. Japan Respiratory Disease Testing Market Revenue, By Product, 2015 2021, (USD Billion) 7.4.4.2. Japan Respiratory Disease Testing Market Revenue, By End-User, 2015 2021 (USD Billion) 7.4.5. India 7.4.5.1. India Respiratory Disease Testing Market Revenue, By Product, 2015 2021, (USD Billion) 7.4.5.2. India Respiratory Disease Testing Market Revenue, By End-User, 2015 2021 (USD Billion) 7.5. Latin America 7.5.1. Latin America Respiratory Disease Testing Market Revenue, By Product, 2015 2021, (USD Billion) 7.5.2. Latin America Respiratory Disease Testing Market Revenue, By End-User, 2015 2021 (USD Billion) 7.5.3. Brazil 7.5.3.1. Brazil Respiratory Disease Testing Market Revenue, By Product, 2015 2021, (USD Billion) 7.5.3.2. Brazil Respiratory Disease Testing Market Revenue, By End-User, 2015 2021 (USD Billion) 7.6. Middle East And Africa 7.6.1. Middle East And Africa Respiratory Disease Testing Market Revenue, By Product, 2015 2021, (USD Billion) 7.6.2. Middle East And Africa Respiratory Disease Testing Market Revenue, By End-User, 2015 2021 (USD Billion) Chapter 8. Company Profile 8.1. ndd Medical Technologies, Inc. 8.1.1. Overview 8.1.2. Financials 8.1.3. Product Portfolio 8.1.4. Business Strategy 8.1.5. Recent Developments 8.2. Carestream Health, Inc. 8.2.1. Overview 8.2.2. Financials 8.2.3. Product Portfolio 8.2.4. Business Strategy 8.2.5. Recent Developments 8.3. SDI Diagnostics 8.3.1. Overview 8.3.2. Financials 8.3.3. Product Portfolio 8.3.4. Business Strategy 8.3.5. Recent Developments 8.4. Nihon Kohden Corporation 8.4.1. Overview 8.4.2. Financials 8.4.3. Product Portfolio 8.4.4. Business Strategy 8.4.5. Recent Developments 8.5. CareFusion Corporation 8.5.1. Overview 8.5.2. Financials 8.5.3. Product Portfolio 8.5.4. Business Strategy 8.5.5. Recent Developments 8.6. Smiths Medical 8.6.1. Overview 8.6.2. Financials 8.6.3. Product Portfolio 8.6.4. Business Strategy 8.6.5. Recent Developments 8.7. COSMED 8.7.1. Overview 8.7.2. Financials 8.7.3. Product Portfolio 8.7.4. Business Strategy 8.7.5. Recent Developments 8.8. Perkin Elmer, Inc. 8.8.1. Overview 8.8.2. Financials 8.8.3. Product Portfolio 8.8.4. Business Strategy 8.8.5. Recent Developments 8.9. Philips Healthcare 8.9.1. Overview 8.9.2. Financials 8.9.3. Product Portfolio 8.9.4. Business Strategy 8.9.5. Recent Developments 8.10. MGC Diagnostic Corporation 8.10.1. Overview 8.10.2. Financials 8.10.3. Product Portfolio 8.10.4. Business Strategy 8.10.5. Recent Developments 8.11. Futuremed America, Inc. 8.11.1. Overview 8.11.2. Financials 8.11.3. Product Portfolio 8.11.4. Business Strategy 8.11.5. Recent Developments 8.12. GE Healthcare 8.12.1. Overview 8.12.2. Financials 8.12.3. Product Portfolio 8.12.4. Business Strategy 8.12.5. Recent Developments

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS